Pulmonology · Sleep-Disordered Breathing
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Obesity hypoventilation syndrome is defined by a BMI ≥ 30 kg/m² and awake alveolar hypoventilation resulting in daytime hypercapnia (PaCO2 > 45 mmHg).
The diagnosis requires the exclusion of other causes of hypercapnia, such as obstructive sleep apnea, COPD, or neuromuscular disease.
Patients typically present with excessive daytime sleepiness, morning headaches, and hypoxemia that worsens during sleep.
Physical examination often reveals signs of cor pulmonale, including peripheral edema, jugular venous distension, and a loud pulmonic component of S2.
Arterial blood gas analysis demonstrates chronic respiratory acidosis with metabolic compensation (elevated serum bicarbonate).
The first-line treatment for stable patients is positive airway pressure (PAP) therapy, typically bilevel positive airway pressure (BiPAP).
Weight loss via bariatric surgery or lifestyle modification is the definitive long-term management to improve respiratory mechanics and gas exchange.
Vignette unlocked
A 52-year-old male with a BMI of 42 kg/m² presents to the clinic complaining of excessive daytime sleepiness and morning headaches. He reports frequent snoring and witnessed apnea by his spouse. Physical exam reveals bilateral lower extremity edema and a loud P2 heart sound. Laboratory studies show a serum bicarbonate of 32 mEq/L. An arterial blood gas obtained while the patient is awake shows a PaCO2 of 52 mmHg and a PaO2 of 62 mmHg.
What is the most likely diagnosis?
Obesity hypoventilation syndrome
The patient meets the diagnostic criteria of obesity (BMI > 30), daytime hypercapnia (PaCO2 > 45 mmHg), and compensatory metabolic alkalosis (elevated bicarbonate) in the absence of other primary lung diseases.
Full handout
High yield triage
Etiology / Epidemiology
Occurs in patients with BMI > 30 kg/m² and chronic alveolar hypoventilation.
Clinical Manifestations
Presents with Pickwickian syndrome features: daytime hypersomnolence and dyspnea.
Diagnosis
Confirmed by arterial blood gas showing PaCO2 > 45 mmHg while awake.
Treatment
First-line is positive airway pressure (PAP); avoid sedatives.
Prognosis
High risk of pulmonary hypertension and cor pulmonale.
Full handout
Epidemiology & Etiology
Primarily affects patients with morbid obesity (BMI ≥ 30 kg/m²). It is a diagnosis of exclusion in patients who lack other causes of hypoventilation, such as neuromuscular disease or severe obstructive lung disease. Prevalence increases significantly as BMI exceeds 40 kg/m².
Pertinent Anatomy
Excessive adipose tissue in the chest wall and abdomen restricts thoracic compliance. This mechanical load increases the work of breathing and reduces functional residual capacity. Upper airway anatomy often contributes to concurrent obstructive sleep apnea.
Pathophysiology
Chronic hypoventilation leads to hypercapnia and hypoxemia. The respiratory center becomes desensitized to CO2, causing a blunted ventilatory response. Over time, this results in respiratory acidosis and secondary polycythemia as a compensatory mechanism for chronic hypoxia.
Clinical Manifestations
Patients present with Pickwickian syndrome, characterized by daytime hypersomnolence, fatigue, and morning headaches. Physical exam reveals obesity, peripheral edema, and signs of right-sided heart failure. Red flags include cyanosis, severe lethargy, and signs of acute respiratory failure.
Diagnosis
The gold standard is an arterial blood gas (ABG) demonstrating PaCO2 > 45 mmHg in the absence of other causes. A polysomnography is required to evaluate for concurrent obstructive sleep apnea. Serum bicarbonate is typically elevated (> 27 mEq/L) due to chronic metabolic compensation.
Treatment
The first-line treatment is positive airway pressure (PAP), typically via CPAP or BiPAP. Weight loss is the definitive long-term management. Avoid sedatives and opioids, as they further suppress the respiratory drive and can precipitate acute respiratory failure.
Prognosis
Untreated patients face high mortality from pulmonary hypertension and cor pulmonale. Long-term adherence to PAP therapy is essential to prevent progression to chronic respiratory failure and cardiac arrhythmias.
Differential Diagnosis
Obstructive sleep apnea: PaCO2 is usually normal while awake
COPD: Characterized by obstructive spirometry patterns
Hypothyroidism: Check TSH to rule out metabolic causes of fatigue
Neuromuscular disease: Look for weakness or abnormal pulmonary function tests
Heart failure: Distinguish by BNP levels and echocardiogram findings